BioWorld

Jan. 3, 2008

View Archived Issues

BioWorld's Report Looks at Biotechnology Executive Pay

Read More

Other News To Note

Read More

Clinic Roundup

Read More

Bankers Say Selective Windows, Low Prices Will Continue in 2008

The window for biotech initial public offerings cracked open several times in 2007, letting out a cool burst of post-JPMorgan deals, a fresh breeze of spring offerings and a gust of fall pricings. (BioWorld Today) Read More

Sepracor in $175M Deal with Bial for Epilepsy Drug

Read More